Breast Cancer and Genetics

The two most common genetic risk factors for breast cancer are the BRCA1 & BRCA2 genes. Approximately 5% of all breast cancers are caused by a recognised specific genetic predisposition due to germ line mutations of one of two different genes: BRCA1 located on Chromosome 17q, BRCA2 located on Chromosome 13q. BRCA1 mutations also predispose to carcinoma of the ovary and possibly carcinoma of the Fallopian tube. The risk of developing breast cancer among carriers is around 55% by age 70. BRCA2: The product of BRCA2 is involved in controlling gene function and DNA repair. Gene function involves in transcriptional activation and completion of cell division by cytokinesis.  Majority of BRCA2-associated tumours are invasive ductal, no special-type tumours

  • Testing for BRCA1 & 2
  • Ataxia telangiectasia mutation (ATM)
  • Hereditary breast cancers genes
  • Prognosis

Related Conference of Breast Cancer and Genetics

May 9-10, 2019

17th European Pathology Congress

| Amsterdam, Netherlands
June 28-29, 2019

Breast Pathology and Cancer

Oslo, Norway
July 31 - August 1, 2019

International Conference on Surgical Pathology

Amsterdam,Netherlands
July 31- August 01, 2019

International Conference on Molecular Pathology

Amsterdam | Netherlands
August 21-22, 2019

17th Asia Pacific Pathology Congress

Singapore
November 08-09, 2019

18th Global Congress on Pathology

| San Francisco | United States
November 13-14, 2019

World Congress on Histopathology

Tokyo, Japan
November 25-26, 2019

2nd European Pathology and Infectious Disease Conference

Helsinki, Finland

Breast Cancer and Genetics Conference Speakers

Recommended Sessions

Related Journals

Are you interested in